Linda Lindsay diagnosed with MS in 2007 - Video
Society’s We Keep Moving travel crew captures 10 compelling video stories of people across America living with MS but still moving forward with their lives feedproxy.google.com |
Genzyme's MS Therapy on the Fast Track: Competition Heats Up
EP Vantage submits:The competitive landscape for current first-line treatments for MS, particularly beta interferons, looks increasingly inhospitable. Following last week’s FDA advisory committee recommendation to approve Novartis’ (NVS) Gilenia in early use and potentially the first oral MS drug (Gilenia clears major regulatory hurdle with surprising ease, June 11, 2010), the threat posed by a launch in 2012 of Campath in the MS market was highlighted again Monday with FDA fast track status for the antibody which Genzyme (GENZ) acquired from Bayer (BAYRY.PK) last year.While Gilenia demonstrated superior efficacy over Biogen Idec’s (BIIB) Avonex, Campath is being tested directly against another beta interferon, Merck KGaA (MKGAY.PK) and Pfizer’s (PFE) Rebif, with results from two phase III trials expected in the second half of 2011. Although Genzyme did not pay anything upfront for global rights to Campath in MS, the troubled biotech clearly sees huge potential in MS with potential payments to Bayer reaching $1.2bn.Complete Story » seekingalpha.com |
New Superbug Spurs Warning
Some bacteria have learned a new way to deactivate the antibiotics that usually kill them, raising concerns about a novel wave of drug-resistant "superbugs" that travelers could spread world-wide. online.wsj.com |
Study Examines Sugar as Pain Reliever for Tots
In The Research Report, Jeremy Singer-Vine summarizes new medical findings on infant pain; circadian rhythms; lung cancer; cognitive exercise; migraine; low-carbohydrate diets; esophageal cancer and heart health. online.wsj.com |
Drug Firm Sues FDA Over Heparin Imports
Amphastar Pharmaceuticals Sued the FDA, saying the agency improperly held up imports of its raw heparin product this year. online.wsj.com |